Cognitive capacities, increased memory, increased learning ability and improved verbal acuity.
Mostly a crystalline solid, noopept is a brand that contains n-phenyl acetyl-l-polyglycine ethyl ester, a synthetic molecule. Noopept is not in its active form until it’s metabolized to cyclopropyl glycine. N-methyl-d-aspartate receptor and AMPA receptor sites and their pathways are acted upon by the noopept. It binds with glutamate and in the process reduces breakdown. The fact that it also has a high affinity for acetylcholine and ACH receptor sites means it has a broad range of nootropic benefits.
This synthetic compound peptide can improve nootropic and cognitive effects (increased memory capacity, longer attention spans, and general cognitive improvement). It has the potential to reduce neurodegenerative problems by countering amyloid induced cytotoxity, and hence reducing adverse effects on the neuroblastoma cells. It increases the levels of the nerve growth factor which is responsible for the growth, maintenance, and survival of nerve cells. In general, when administered, it stimulates hormones that act to promote the growth of neurons, their differentiation, and the creation of new synapses.
Some studies also show that noopept can act as an anti-diabetic agent, and that it has shown antioxidant and anti-inflammatory properties. This drug has been shown to be stronger than the drug in the racetam family, called piracetam. Its potency is about a thousand times that of common racetams. Noopept targets and acts on serototin receptors which can boost moods.
It is also being used for the possible treatment of Alzheimer’s in patients. Alzheimer’s is a condition that is associated with problems in memory, behaviour, and thinking which grows worse with time and may end up disrupting the daily activities of the affected patient. Also worth noting is that this drug is being researched to see if it can treat post traumatic cognitive deficiency and cerebrovascular cause.